NasdaqGS:REGNBiotechs
Regeneron Pharmaceuticals (NasdaqGS:REGN) Exits Multiple Russell Growth Indices
On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month, the company's shares increased by 6%, a move that coincides with Regeneron's Dupixent approval for bullous pemphigoid and its addition to the Russell 1000 Dynamic Index. These events align with broader market trends, as major U.S. indices, including the S&P 500 and Nasdaq, have rallied to new highs...